Provided by Tiger Fintech (Singapore) Pte. Ltd.

LIFECORE BIOMEDICAL INC

6.38
+0.21003.40%
Post-market: 6.380.00000.00%16:05 EDT
Volume:155.72K
Turnover:979.96K
Market Cap:236.22M
PE:-4.28
High:6.40
Open:6.10
Low:6.10
Close:6.17
Loading ...
Oct 04, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 04, 2024

Major Issues Report

Form 8-K - Current report
Sep 23, 2024

Major Issues Report

Form 8-K - Current report
Sep 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 12, 2024

Major Issues Report

Form 8-K - Current report
Aug 29, 2024

Major Issues Report

Form 8-K - Current report
Aug 26, 2024

Major Issues Report

Form 8-K - Current report
Aug 26, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Aug 21, 2024

Major Issues Report

Form 8-K - Current report
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 24, 2024

Major Issues Report

Form 8-K - Current report
Jul 12, 2024

Major Issues Report

Form 8-K - Current report
Jul 05, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Jul 01, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Jul 01, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Jul 01, 2024

Major Issues Report

Form 8-K - Current report
Jun 11, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 08, 2024

Correspondence

Form CORRESP - Correspondence